Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993
Annals of OncologyPublished 1 August 2000Open access
Fabio Levi, Lalao Randimbison, V.-C. Te, Silvia Franceschi, Carlo La Vecchia
Citations40
SJR quartileQ1
SJR score19.07
SNIP10.48
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Survival estimates for most cancer sites are comparable to the US SEER dataset, and their pattern of trends are discussed in terms of improved diagnosis and treatment for various neoplasms.
Abstract
Survival estimates for most cancer sites are comparable to the US SEER dataset, and their pattern of trends are discussed in terms of improved diagnosis and treatment for various neoplasms.
Keywords
Medicine
Springer series in statisticsNonparametric Estimation from Incomplete Observations
45,533 Citations1992Edward L. Kaplan, Paul Meier
Journal of the American Statistical AssociationNonparametric Estimation from Incomplete Observations
39,052 Citations1958Edward L. Kaplan, Paul Meier
Cancer Incidence in Five Continents
8,539 Citations1970Richard Doll, C. S. Muir +1 more
British Journal of CancerDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
8,392 Citations1977Richard Peto, M. C. Pike +8 more
Efficient methods of analysis of randomized clinical trials in which the authors wish to compare the duration of survival among different groups of patients are described.
JNCI Journal of the National Cancer InstituteTamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
5,508 Citations1998Bernard Fisher, Joseph P. Costantino +15 more
Tamoxifen decreases the incidence of invasive and noninvasive breast cancer and its use as a breast cancer preventive agent is appropriate in many women at increased risk for the disease.
The LancetTamoxifen for early breast cancer: an overview of the randomised trials
4,105 Citations1998Early Breast Cancer Tr.group, -, Klijn, Jan
The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
CA A Cancer Journal for CliniciansCancer statistics, 2000
3,890 Citations2000Robert T. Greenlee, Thomas S. Murray +2 more
The Surveillance Research Program of the American Cancer Society's Department of Epidemiology and Surveillance Research reports its annual compilation of estimated cancer incidence, mortality, and survival data for the United States in the year 2000.
DefinitionsInternational Classification of Diseases for Oncology
3,826 Citations2020National Cancer Institute
The LancetEarly Lung Cancer Action Project: overall design and findings from baseline screening
2,512 Citations1999Claudia I. Henschke, Dorothy I. McCauley +9 more
Low-dose CT can greatly improve the likelihood of detection of small non-calcified nodules, and thus of lung cancer at an earlier and potentially more curable stage, although false-positive CT results are common.
New England Journal of MedicineAcute Lymphoblastic Leukemia
838 Citations1998Ching‐Hon Pui, William E. Evans
BMJCancer trends in England and Wales
211 Citations2000Heather O Dickinson
A trend suggests that the government is off to a flying start and its target to reduce the death rate from cancer in people under 75 years by at least a fifth by 2010, and the basis of the target has not yet been published.
Acta OncologicaSurvival of Cancer Patients in Finland 1955-1994
181 Citations1999Paul W. Dickman, Timo Hakulinen +5 more
European Journal of CancerCancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994
152 Citations1999Fabio Levi, F Lucchini +3 more
Cancer mortality was still upwards in a few southern and eastern European countries, including Hungary and Poland, where total cancer mortality rates in middle-aged males are now the highest ever registered in Europe.
Journal of Clinical OncologyImproved survival for patients with acute myelogenous leukemia.
112 Citations1995Anna Mitus, K B Miller +5 more
The long-term disease-free survival observed in this study is excellent compared with historical data, probably due to the high rate of remission induction, as well as to the effective nature of the consolidation therapy.
European Journal of CancerThe EUROCARE II study
84 Citations1998Franco Berrino, Gemma Gatta +3 more
This introduction provides a general overview of the aims, methods and procedures used in the EUROCARE II study and the types of analyses presented in each article of this Special Issue of the European Journal of Cancer.
BMJHow many deaths have been avoided through improvements in cancer survival?
81 Citations2000M A Richards
If recent rates of improvement in cancer survival continue, about 24 000 deaths within five years of diagnosis would be avoided in patents aged under 75 by the year 2010, representing about a quarter of the government's overall target of 100 000 fewer cancer deaths.
International Journal of CancerPrognostic factors for cutaneous malignant melanoma in Vaud, Switzerland
42 Citations1998Fabio Levi, Lalao Randimbison +3 more
Trends in survival from cutaneous malignant melanoma in relation to patient and tumor characteristics were considered, using data from the Cancer Registry of the Swiss Canton of Vaud, and the pattern was similar for most prognostic factors considered up to 10 years after diagnosis.
European Journal of CancerPatterns of childhood cancer incidence and mortality in Europe
38 Citations1992Fabio Levi, Carlo La Vecchia +3 more
There is ample scope for further reduction in childhood cancer mortality in several eastern and some southern European countries, according to the observed pattern of trends, which likely reflects the different adoption and impact of newer efficacious therapies of childhood cancer.
Anti-Cancer DrugsProgress of anticancer drugs in reducing mortality from selected cancers in Europe
33 Citations1991Carlo La Vecchia, Fabio Levi +2 more
Almost 11,000 deaths per year were avoided in Europe by newer cancer treatments between the late 1950s and the late 1980s, corresponding to 1% cancer deaths registered in the 23 larger European countries.
European Journal of CancerTrends in cancer survival in Vaud, Switzerland
32 Citations1992Fabio Levi, Lalao Randimbison +3 more
Changes in survival were greater or restricted to younger individuals for testis, bladder and leukaemias and cancer of the mouth or pharynx (decline), thus suggesting the different play of age-specific biological characteristics of some tumours, in addition to diagnostic improvements and gradual spread of effective cancer treatments to more advanced age groups.
BMJMortality from breast cancer in UK has decreased suddenly
29 Citations1998Richard Peto
Trends in mortality from breast cancer in the United Kingdom are much more encouraging than Wise's news article indicates.
CancerLong-term survival of patients with acute myeloid leukemia
15 Citations1997Clara D. Bloomfield, Geoffrey P. Herzig +2 more
Results from a 1981 and 1989 report on a study conducted by the University of Minnesota Masonic Cancer Center and the North American Marrow Transplant Group are updated.
The LancetEUROCARE-2: relevance for assessment of quality of cancer services?
14 Citations2000Les Irwig, Bruce K. Armstrong
International Journal of EpidemiologyNon-Hodgkin's lymphoma: time trends for incidence and survival in Cote- d'Or, France
14 Citations1997Isabelle Rolland-Portal
Although incidence of NHL has increased in Côte-d'Or, this trend has remained independent of the AIDS epidemic and neither sex, age, period of diagnosis nor place of hospitalization were significant prognostic factors.